S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
NASDAQ:QDEL

QuidelOrtho - QDEL Stock Forecast, Price & News

$84.09
-3.11 (-3.57%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$83.39
$87.89
50-Day Range
$84.09
$107.63
52-Week Range
$83.39
$180.06
Volume
979,069 shs
Average Volume
731,292 shs
Market Capitalization
$5.63 billion
P/E Ratio
3.56
Dividend Yield
N/A
Price Target
$98.67

QuidelOrtho MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
17.3% Upside
$98.67 Price Target
Short Interest
Bearish
4.65% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-2.61
Upright™ Environmental Score
News Sentiment
0.20mentions of QuidelOrtho in the last 14 days
Based on 12 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
-54.57%
From $11.60 to $5.27 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.88 out of 5 stars

Medical Sector

888th out of 1,135 stocks

Diagnostic Substances Industry

12th out of 17 stocks

QDEL stock logo

About QuidelOrtho (NASDAQ:QDEL) Stock

QuidelOrtho Corporation provides various in vitro diagnostics products worldwide. The company's product portfolio covers a range of point-of-care tests for infectious diseases, critical cardiac health and autoimmune biomarkers, and clinical and at-home products to detect COVID-19. It provides visually-read lateral flow products in infectious disease and reproductive health; direct fluorescent antibodies in infectious disease and virology; micro-titer production with a focus on bone and complement pathway markets; fluorescent immunoassay products; molecular diagnostic products comprising Savanna, an integrated molecular diagnostic system; immunodiagnostics, clinical chemistry, and integrated testing systems to serve diagnostic labs of all sizes; immunodiagnostic donor screening systems and services that drive blood safety; pre-transfusion testing that automates blood bank workload with software to standardize operations, simplify tasks, and improve productivity; and Ortho Care services and informatics products. The company was founded in 1979 and is headquartered in San Diego, California.

QuidelOrtho Price Performance

NASDAQ:QDEL opened at $84.09 on Friday. QuidelOrtho has a 52 week low of $83.39 and a 52 week high of $180.06. The firm has a market cap of $5.63 billion, a price-to-earnings ratio of 3.56 and a beta of 0.03. The firm's 50-day simple moving average is $99.03 and its 200 day simple moving average is $101.75. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.94 and a current ratio of 1.73.

Analyst Ratings Changes

Several research analysts recently commented on the stock. StockNews.com upgraded shares of QuidelOrtho from a "hold" rating to a "buy" rating in a report on Friday, May 13th. UBS Group began coverage on shares of QuidelOrtho in a research report on Wednesday, July 20th. They set a "sell" rating and a $86.00 target price on the stock. Finally, JPMorgan Chase & Co. started coverage on shares of QuidelOrtho in a research note on Friday, June 17th. They set a "neutral" rating for the company. One analyst has rated the stock with a sell rating, one has given a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, QuidelOrtho presently has an average rating of "Moderate Buy" and a consensus price target of $98.67.

Receive QDEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for QuidelOrtho and its competitors with MarketBeat's FREE daily newsletter.

QDEL Stock News Headlines

QuidelOrtho (QDEL) Q2 2022 Earnings Call Transcript
QuidelOrtho: Q2 Earnings Snapshot
QuidelOrtho (QDEL) Scheduled to Post Earnings on Thursday
QuidelOrtho (NASDAQ:QDEL) Trading 4% Higher
See More Headlines
Receive QDEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for QuidelOrtho and its competitors with MarketBeat's FREE daily newsletter.

QDEL Company Calendar

Last Earnings
11/04/2021
Today
8/14/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Diagnostic substances
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:QDEL
CUSIP
74838J10
Employees
1,600
Year Founded
1979

Price Target and Rating

Average Stock Price Forecast
$98.67
High Stock Price Forecast
$130.00
Low Stock Price Forecast
$80.00
Forecasted Upside/Downside
+17.3%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$704.23 million
Pretax Margin
47.80%

Debt

Sales & Book Value

Annual Sales
$1.70 billion
Cash Flow
$19.15 per share
Book Value
$73.48 per share

Miscellaneous

Free Float
65,145,000
Market Cap
$5.63 billion
Optionable
Optionable
Beta
0.03

Social Links


Key Executives

  • Mr. Douglas C. Bryant (Age 64)
    Chairman & CEO
    Comp: $1.41M
  • Mr. Robert J. Bujarski J.D. (Age 53)
    Pres & COO
    Comp: $770.62k
  • Ms. Michelle A. Hodges (Age 62)
    Gen. Counsel
    Comp: $620.61k
  • Dr. Werner Kroll Ph.D. (Age 65)
    Sr. VP of R&D
    Comp: $758.22k
  • Mr. Joseph M. Busky CPA (Age 54)
    Chief Financial Officer
  • Ruben Argueta
    Director of Investor Relations
  • Mr. Michael S. Iskra (Age 52)
    Chief Commercial Officer
  • Phillip S. Askim
    VP, Associate Gen. Counsel & Sec.
  • Dr. Johannes Kehle
    Pres of AnDiaTec Division
  • Mr. Rhys de Callier
    VP of Strategy & Portfolio Management













QDEL Stock - Frequently Asked Questions

Should I buy or sell QuidelOrtho stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for QuidelOrtho in the last twelve months. There are currently 1 sell rating, 1 hold rating and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" QDEL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in QDEL, but not buy additional shares or sell existing shares.
View QDEL analyst ratings
or view top-rated stocks.

What is QuidelOrtho's stock price forecast for 2022?

3 equities research analysts have issued 12 month price objectives for QuidelOrtho's stock. Their QDEL share price forecasts range from $80.00 to $130.00. On average, they anticipate the company's stock price to reach $98.67 in the next year. This suggests a possible upside of 17.3% from the stock's current price.
View analysts price targets for QDEL
or view top-rated stocks among Wall Street analysts.

How have QDEL shares performed in 2022?

QuidelOrtho's stock was trading at $134.99 at the start of the year. Since then, QDEL stock has decreased by 37.7% and is now trading at $84.09.
View the best growth stocks for 2022 here
.

When is QuidelOrtho's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our QDEL earnings forecast
.

How were QuidelOrtho's earnings last quarter?

QuidelOrtho Co. (NASDAQ:QDEL) released its quarterly earnings data on Thursday, November, 4th. The company reported $5.36 EPS for the quarter, beating analysts' consensus estimates of $3.52 by $1.84. The company had revenue of $509.70 million for the quarter, compared to analyst estimates of $344.25 million. QuidelOrtho had a net margin of 36.43% and a trailing twelve-month return on equity of 42.55%. The business's revenue was up 7.1% compared to the same quarter last year. During the same period last year, the business posted $5.68 EPS.

What guidance has QuidelOrtho issued on next quarter's earnings?

QuidelOrtho updated its FY 2022 earnings guidance on Friday, August, 12th. The company provided earnings per share guidance of $11.80-$12.75 for the period. The company issued revenue guidance of $3.78 billion-$3.91 billion, compared to the consensus revenue estimate of $2.83 billion.

What is Doug Bryant's approval rating as QuidelOrtho's CEO?

47 employees have rated QuidelOrtho Chief Executive Officer Doug Bryant on Glassdoor.com. Doug Bryant has an approval rating of 76% among the company's employees.

What other stocks do shareholders of QuidelOrtho own?

Based on aggregate information from My MarketBeat watchlists, some companies that other QuidelOrtho investors own include NVIDIA (NVDA), DocuSign (DOCU), Tesla (TSLA), PayPal (PYPL), Shopify (SHOP), Block (SQ), Teladoc Health (TDOC), Netflix (NFLX), Advanced Micro Devices (AMD) and Zoom Video Communications (ZM).

What is QuidelOrtho's stock symbol?

QuidelOrtho trades on the NASDAQ under the ticker symbol "QDEL."

Who are QuidelOrtho's major shareholders?

QuidelOrtho's stock is owned by many different retail and institutional investors. Top institutional shareholders include Carlyle Group Inc. (29.77%), JPMorgan Chase & Co. (2.07%), Massachusetts Financial Services Co. MA (1.07%), Renaissance Technologies LLC (1.51%), Lazard Asset Management LLC (1.23%) and Burgundy Asset Management Ltd. (1.18%). Insiders that own company stock include Charles P Slacik, Douglas C Bryant, Edward Keith Russell, Edward L Michael, Karen Gibson, Kenneth F Buechler, Mary Lake Ph D Polan, Matthew Strobeck, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, Werner Kroll, William J Ferenczy and William J Ferenczy.
View institutional ownership trends
.

How do I buy shares of QuidelOrtho?

Shares of QDEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is QuidelOrtho's stock price today?

One share of QDEL stock can currently be purchased for approximately $84.09.

How much money does QuidelOrtho make?

QuidelOrtho (NASDAQ:QDEL) has a market capitalization of $5.63 billion and generates $1.70 billion in revenue each year. The company earns $704.23 million in net income (profit) each year or $23.60 on an earnings per share basis.

How many employees does QuidelOrtho have?

The company employs 1,600 workers across the globe.

When was QuidelOrtho founded?

QuidelOrtho was founded in 1979.

How can I contact QuidelOrtho?

QuidelOrtho's mailing address is 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA, 92121. The official website for the company is www.quidel.com. The company can be reached via phone at (858) 552-1100, via email at rargueta@quidel.com, or via fax at 858-453-4338.

This page (NASDAQ:QDEL) was last updated on 8/14/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.